Dynamic monitoring of serum tumor markers as prognostic factors in patients with advanced non-small-cell lung cancer treated with first-line immunotherapy: a multicenter retrospective study

BACKGROUND: To date, no specific studies have reported the use of dynamic serum tumor markers (STMs) as prognostic factors in patients with advanced non-small-cell lung cancer (NSCLC) who receive first-line immunotherapy. Therefore, it is unclear whether STMs can be used as a prognostic factor for f...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiongwen, Xiao, Yi, Zhou, Yubin, Deng, Huiyin, Yuan, Zihao, Dong, Longyan, Lan, Jun, Hu, Hao, Huang, Jian, Huang, Shaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619361/
https://www.ncbi.nlm.nih.gov/pubmed/37920256
http://dx.doi.org/10.1177/17588359231206282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619361/
https://www.ncbi.nlm.nih.gov/pubmed/37920256
http://dx.doi.org/10.1177/17588359231206282

Ejemplares similares